These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Advances in the diagnosis and management of impotence. Wierman ME Adv Intern Med; 1999; 44():1-17. PubMed ID: 9929703 [No Abstract] [Full Text] [Related]
48. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury]. Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629 [TBL] [Abstract][Full Text] [Related]
49. Cigarette smoking and other vascular risk factors in vasculogenic impotence. Shabsigh R; Fishman IJ; Schum C; Dunn JK Urology; 1991 Sep; 38(3):227-31. PubMed ID: 1887536 [TBL] [Abstract][Full Text] [Related]
50. Dynamic pharmacocavernosometry: a search for an ideal approach. Motiwala HG Urol Int; 1993; 51(1):1-8. PubMed ID: 8333085 [TBL] [Abstract][Full Text] [Related]
51. [Erection disorders. I: Anatomical-physiological bases and diagnostic assessment]. Böss HP; Knönagel H; Hauri D Schweiz Rundsch Med Prax; 1991 Nov; 80(45):1240-5. PubMed ID: 1947560 [TBL] [Abstract][Full Text] [Related]
52. Diagnosis and therapy of erectile dysfunction using papaverine and phentolamine. Zentgraf M; Baccouche M; Jünemann KP Urol Int; 1988; 43(2):65-75. PubMed ID: 3291360 [TBL] [Abstract][Full Text] [Related]
53. [Investigation of intracavernous injection of papaverine for erectile impotence]. Takimoto Y; Kawazoe K; Hosokawa H; Hamada T; Ono M; Aoki Y; Yasuoka S Hinyokika Kiyo; 1989 Jan; 35(1):71-6. PubMed ID: 2729023 [TBL] [Abstract][Full Text] [Related]
54. The effect of intracavernosal injection of papaverine hydrochloride on orgasm latency. Levitt EE; Mulcahy JJ J Sex Marital Ther; 1995; 21(1):39-41. PubMed ID: 7608997 [TBL] [Abstract][Full Text] [Related]
55. [The treatment of male organic impotence of vascular origin]. Proca E; Sinescu I Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1990; 39(1):21-35. PubMed ID: 2149189 [TBL] [Abstract][Full Text] [Related]
56. Diabetes-related impotence and its treatment in the middle-aged and elderly: Part I. Whitehead ED Geriatrics; 1987 Jun; 42(6):63-5, 69-73. PubMed ID: 3582987 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of erectile dysfunction with continuous monitoring of penile rigidity. Kaneko S; Bradley WE J Urol; 1986 Nov; 136(5):1026-9. PubMed ID: 3773061 [TBL] [Abstract][Full Text] [Related]
58. [Guidelines for the diagnosis and treatment of erectile disorders. NVIO (Dutch Society for Impotence Research) and NVU (Dutch Society for Urology)]. Meuleman EJ; Drenth J; van Driel MF; Lycklama à Nijeholt AA Ned Tijdschr Geneeskd; 1995 Sep; 139(37):1874-9. PubMed ID: 7477518 [No Abstract] [Full Text] [Related]
59. Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic male. Bell DS; Cutter GR; Hayne VB; Lloyd LK Urology; 1992 Jul; 40(1):36-40. PubMed ID: 1621310 [TBL] [Abstract][Full Text] [Related]